Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
13.64
+0.14 (1.04%)
Jul 31, 2025, 2:39 PM - Market open
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $4.58 billion as of July 31, 2025. Its market cap has increased by 4.53% in one year.
Market Cap
4.58B
Enterprise Value
4.50B
1-Year Change
4.53%
Ranking
Category
Stock Price
13.64
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $4.58B, an increase of 3,873.38%. That is a compound annual growth rate of 61.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2025 | 4.52B | -11.40% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | 817.72M | 196.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |